Skip to main content
AmigoFish

The Golden Triangle and the gaps: Rethinking UK biotech

From BioSpace · · 19 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you’ll hear from Hakan Goker, managing director at M Ventures and Maina Bhaman, partner at Sofinnova Partners. We explore the UK biotech ecosystem : from the Golden Triangle’s evolving role to the challenges of scaling companies, unlocking pension capital and staying globally competitive.

Host

Jennifer C. Smith-Parker (https://www.linkedin.com/in/jennifersmithparker/), Director of Insights, BioSpace

Guests

Hakan Goker (https://www.linkedin.com/in/hakan-goker-a61a674/), Managing Director, M Ventures

Maina Bhaman (https://www.linkedin.com/in/maina-bhaman-b7a229/), Partner, Sofinnova Partners

Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

Back to BioSpace · Report a problem